AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 01/28/26

BRIDGEWATER, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has been added to the S&P SmallCap 600 ® Index. The inclusion will become effective prior to the opening of tr...

2026-01-28 00:18:07 ET More on Civitas Resources, TTM Technologies, etc. Advanced Energy Industries: Growth Expected To Accelerate In 2026 Huntington Bancshares Incorporated (HBAN) Q4 2025 Earnings Call Transcript Huntington Bancshares Incorporated 2025 Q4 - Results ...

TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join ...

BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to ma...

2026-01-21 14:36:34 ET More on pharmaceuticals XPH: Healthcare Dashboard For January Why PPH Keeps Working When Single Themes Break Healthcare Dashboard For December And Focus On PJP Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals ...

2026-01-13 23:36:01 ET Amneal Pharmaceuticals, Inc. (AMRX) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 7:30 PM EST... Read the full article on Seeking Alpha For further details see: Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan He...

2026-01-08 07:20:06 ET More on Gilead Sciences, CVS , etc. Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Call - Slideshow CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript ...

Approvals expand Amneal’s biosimilars portfolio Company expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX...

2025-12-17 23:01:04 ET The Thesis: A Bullish Case Betting on the Future Pipeline Addressing Many Conditions Read the full article on Seeking Alpha For further details see: Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks

2025-12-10 12:56:53 ET More on Teva Pharmaceutical, Amneal Pharmaceuticals Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare...